Over the last few years, the Departments of Justice and Health & Human Services have increased their scrutiny of healthcare providers resulting in a broad range of types of investigations conducted by the FBI, US Attorney Offices and the FDA at hospitals, skilled nursing facilities and other providers. There has been no sign that investigations will decrease under the new administration. Healthcare providers should be aware of the trends and areas that the federal government is pursuing and must be prepared for what to expect in light of the developments in integrated care delivery models that includes mergers, accountable care organizations, and affiliations. All provider organizations are encouraged to attend this timely session where we plan to review current government scrutiny and provide guidance on how to respond if the government does initiate an inquiry. Giselle Joffre, a Partner with MHA’s member law firm of Foley Hoag (and a former Assistant U.S. Attorney within the Civil & Criminal Divisions of the U.S. Attorney's Office in Boston) will be presenting along with other healthcare law experts from Foley Hoag.
This workshop will include presentations on:
• Recent False Claims Act investigations
• Anti Kickback Statute investigations; and
• Allegations of improper billing practices
Faculty from Foley Hoag, LLP:
Thomas Barker is a partner whose practice focuses on complex federal and state health care legal and regulatory matters with a special expertise in Medicare and Medicaid law. Prior to joining Foley Hoag LLP, he was acting General Counsel at the U.S. Department of Health and Human Services (HHS) and General Counsel of the Centers for Medicare & Medicaid Services (CMS).
Giselle J. Joffre is a partner specializing in white collar criminal defense, corporate internal investigations, compliance consulting and complex civil litigation. She is a former federal prosecutor who left the Boston U.S. Attorney’s Office in December 2016 to join Foley Hoag’s litigation department. Her experience as a prosecutor includes investigating False Claims Act violation allegations in the healthcare industry.
Ross Margulies is a senior associate who focuses his practice on Medicare and Medicaid regulatory and compliance issues. Ross has special expertise on Medicaid issues, Medicare reimbursement, the prescription drug 340B program, and providing advice to hospital clients on their obligations under the CMS discharge planning regulations. Ross joined the firm in 2011.
Areta Kupchyk advises health care providers and institutions, researchers, and investors on FDA-related matters. She co-chairs the firm’s Food and Drug Law practice group and is resident in the firm's Washington, D.C. office. Areta draws upon almost 10 years of experience as Associate Chief Counsel for Drugs and Biologics and Assistant General Counsel for Litigation at the FDA to provide clients with nuanced counsel on FDA’s current views for meeting pre- and post-approval requirements.